This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Hepatocyte growth factor
From Proteopedia
(Difference between revisions)
| Line 12: | Line 12: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | *HGF N terminal | + | *HGF N terminal 28-126 |
**[[2hgf]] – hHGF N terminal – human - NMR <br /> | **[[2hgf]] – hHGF N terminal – human - NMR <br /> | ||
| Line 18: | Line 18: | ||
**[[3hmr]] – mHGF N terminal – mouse <br /> | **[[3hmr]] – mHGF N terminal – mouse <br /> | ||
| - | *HGF NK1 variant | + | *HGF NK1 variant 28-210 |
**[[1bht]], [[1nk1]], [[1gp9]], [[2qj2]], [[2qj4]] – hHGF NK1 <br /> | **[[1bht]], [[1nk1]], [[1gp9]], [[2qj2]], [[2qj4]] – hHGF NK1 <br /> | ||
| Line 25: | Line 25: | ||
**[[5ct1]], [[5ct2]], [[5ct3]], [[5cs3]], [[5csq]], [[5cp9]] – hHGF NK1 (mutant) + inhibitor<br /> | **[[5ct1]], [[5ct2]], [[5ct3]], [[5cs3]], [[5csq]], [[5cp9]] – hHGF NK1 (mutant) + inhibitor<br /> | ||
| - | *HGF NK2 variant | + | *HGF NK2 variant 28-289 |
**[[3hn4]] – hHGF NK2 <br /> | **[[3hn4]] – hHGF NK2 <br /> | ||
| Line 31: | Line 31: | ||
**[[4iua]] – mHGF NK2 (mutant) <br /> | **[[4iua]] – mHGF NK2 (mutant) <br /> | ||
| - | *HGF α chain (69 kD) | + | * HGF α chain (69 kD) 495-728 |
| - | **[[ | + | **[[1si5]] – hHGF α chain (mutant) <br /> |
| + | **[[1shy]] – hHGF α chain (mutant) + HGF receptor Sema and ψ domains<br /> | ||
| - | *HGF β chain | + | *HGF β chain 25-567 |
| - | **[[ | + | **[[4o3t]], [[4o3u]] – hHGF β chain (mutant) + HGF receptor Sema and ψ domains + zymogen activator peptide<br /> |
| - | + | ||
*HGF α+β chain | *HGF α+β chain | ||
**[[4k3j]] – hHGF α (mutant) + β + antibody <br /> | **[[4k3j]] – hHGF α (mutant) + β + antibody <br /> | ||
| + | **[[6lz9]] – hHGF α (mutant) + K4 domain 388-494 + antibody <br /> | ||
| + | }} | ||
| + | |||
== References == | == References == | ||
<references/> | <references/> | ||
| - | + | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 08:44, 17 August 2020
| |||||||||||
3D structures of hepatocyte growth factor
Updated on 17-August-2020
References
- ↑ Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res. 1991;3(1):67-85. PMID:1838014
- ↑ Jakubczak JL, LaRochelle WJ, Merlino G. NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo. Mol Cell Biol. 1998 Mar;18(3):1275-83. PMID:9488442
- ↑ Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology. 1995 Jan;21(1):106-12. PMID:7806142
- ↑ Anan F, Masaki T, Yonemochi H, Takahashi N, Nakagawa M, Eshima N, Saikawa T, Yoshimatsu H. Hepatocyte growth factor levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in patients with type 2 diabetes mellitus. Metabolism. 2009 Feb;58(2):167-73. doi: 10.1016/j.metabol.2008.09.009. PMID:19154948 doi:http://dx.doi.org/10.1016/j.metabol.2008.09.009
- ↑ Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology. 1995 Jan;21(1):106-12. PMID:7806142
- ↑ Funakoshi H, Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta. 2003 Jan;327(1-2):1-23. PMID:12482615

